Internal Medicine, American University of Beirut, Beirut, Lebanon.
Int J Neurosci. 2010 Apr;120(4):273-9. doi: 10.3109/00207450903541087.
Adherence to therapy is a key issue in chronic illnesses. In addition, several features of multiple sclerosis (MS) and its treatment may increase the likelihood of patient nonadherence and discontinuation of treatment. Nonadherence will obviously compromise the efficacy of disease-modifying drugs in patients with MS. This subject was discussed by a group of local MS specialists from the Middle East. The group debated several key questions about the features and causes of patient nonadherence and its management. Further, they made recommendations for optimizing treatment adherence in this area.
治疗依从性是慢性病的关键问题。此外，多发性硬化症 (MS) 的几个特征及其治疗方法可能会增加患者不依从治疗和停止治疗的可能性。不依从治疗显然会降低多发性硬化症患者疾病修饰药物的疗效。中东的一组多发性硬化症专家讨论了这个主题。该小组就患者不依从的特征和原因及其管理方面的几个关键问题进行了辩论。此外，他们还就如何优化该领域的治疗依从性提出了建议。
